Brainstorm Cell Therapeutics Inc.
BCLI
$1.22
$0.010.83%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 187.00K | 168.00K | 3.47M | 779.00K | 1.30M |
| Total Receivables | 63.00K | 40.00K | 33.00K | 26.00K | 51.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 135.00K | 156.00K | 314.00K | 454.00K | 548.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 385.00K | 364.00K | 3.82M | 1.26M | 1.90M |
|
|
|||||
| Total Current Assets | 385.00K | 364.00K | 3.82M | 1.26M | 1.90M |
| Net Property, Plant & Equipment | 1.24M | 1.46M | 1.67M | 1.89M | 2.10M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00 | -- | -- | -- | 3.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 206.00K | 203.00K | 199.00K | 202.00K | 207.00K |
| Total Assets | 1.83M | 2.03M | 5.68M | 3.35M | 4.21M |
|
|
|||||
| Total Accounts Payable | 6.08M | 4.60M | 5.34M | 4.69M | 4.95M |
| Total Accrued Expenses | 619.00K | 865.00K | 718.00K | 636.00K | 1.24M |
| Short-term Debt | 300.00K | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 549.00K | 570.00K | 566.00K | 588.00K | 603.00K |
| Total Finance Division Other Current Liabilities | 1.43M | 1.04M | 1.07M | 917.00K | 1.00M |
| Total Other Current Liabilities | 1.43M | 1.04M | 1.07M | 917.00K | 1.00M |
| Total Current Liabilities | 8.98M | 7.08M | 7.69M | 6.83M | 7.80M |
|
|
|||||
| Total Current Liabilities | 8.98M | 7.08M | 7.69M | 6.83M | 7.80M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 300.00K | -- | -- | -- | -- |
| Capital Leases | 171.00K | 271.00K | 396.00K | 533.00K | 672.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 447.00K | 729.00K | 1.12M | 1.53M | 594.00K |
| Total Liabilities | 9.60M | 8.08M | 9.21M | 8.90M | 9.07M |
|
|
|||||
| Common Stock & APIC | 218.99M | 217.72M | 217.54M | 212.98M | 210.27M |
| Retained Earnings | -226.64M | -223.66M | -220.96M | -218.41M | -215.01M |
| Treasury Stock & Other | -116.00K | -116.00K | -116.00K | -116.00K | -116.00K |
| Total Common Equity | -7.76M | -6.06M | -3.53M | -5.55M | -4.86M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -7.76M | -6.06M | -3.53M | -5.55M | -4.86M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.76M | -6.06M | -3.53M | -5.55M | -4.86M |
|
|
|||||